![](/img/cover-not-exists.png)
Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
Yasuhiro Oki, Michinori Ogura, Harumi Kato, Ako Kikuchi, Hirofumi Taji, Yoshitoyo Kagami, Aya Oshiro, Akane Tsujimura, Kazuhito Yamamoto, Yasuo MorishimaVolume:
99
Year:
2008
Language:
english
DOI:
10.1111/j.1349-7006.2007.00662.x
File:
PDF, 107 KB
english, 2008